Patent intelligence · AU
AU 2007332640
Powder formulation for valganciclovir
Powder formulation for valganciclovir
Patent details — AU 2007332640
- Jurisdiction
- AU
- Status
- granted
- Grant date
- Jun 19, 2008
- Expiration
- Jun 14, 2028
- Applicant
- HOFFMANN LA ROCHE [DE]
- CPC classes
- A61K 9/ 14 A I, A61K 9/ 16 A I, A61K 31/ 522 A I, A61K/31522
Quick answer
AU 2007332640 (Powder formulation for valganciclovir) is held by HOFFMANN LA ROCHE [DE]. Status: granted. Granted Jun 19, 2008. Expires Jun 14, 2028 (2 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- HOFFMANN LA ROCHE [DE]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 9/ 14 A I, A61K 9/ 16 A I, A61K 31/ 522 A I, A61K/31522, A61K/4710, A61K/4712
More from HOFFMANN LA ROCHE [DE]
Related pharmaceutical patents in our USPTO index.
-
AU 2001289696
New use of lipase inhibitors
granted -
AU 2001289699
New pharmaceutical composition
expired -
AU 2002212120
Lipase inhibitors for the treatment of dyspepsia
expired -
AU 2001281846
Method for preparing a composition
expired -
AU 2002319189
Pharmaceutical compositions comprising orlistat and fatty acids and/or salts thereof
expired -
AU 2002257817
Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester
expired -
AU 2003222814
PHARMACEUTICAL COMPOSITION COMPRISING A LIPASE INHIBITOR AND GLUCOMANNAN
expired
Frequently asked questions
What is US patent 2007332640?
AU 2007332640 (Powder formulation for valganciclovir) is held by HOFFMANN LA ROCHE [DE]. Status: granted. Granted Jun 19, 2008. Expires Jun 14, 2028 (2 years remaining) — relevant for patent-cliff and LOE planning.
Who owns AU 2007332640?
HOFFMANN LA ROCHE [DE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 10 pharmaceutical patents for this assignee.
When does AU 2007332640 expire?
Our index shows an expiration date of Jun 14, 2028 (2 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.